SYBT
APLS

Stock Yards Bank & Trust’s Apellis Pharmaceuticals APLS Stock Holding History

Stock Yards Bank & Trust’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-5,000
Closed -$456K – 387
2023
Q2 		$456K Sell
5,000
-4,532
-48% -$391K 0.02% 289
2023
Q1 		$629K Sell
9,532
-1,683
-15% -$97.1K 0.02% 261
2022
Q4 		$580K Buy
11,215
+1,715
+18% +$91K 0.02% 273
2022
Q3 		$649K Sell
9,500
-3,500
-27% -$207K 0.03% 258
2022
Q2 		$588K Buy
+13,000
New +$593K 0.02% 271

Other funds holding APLS

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Stock Yards Bank & Trust's APLS Position: Q3 2023 in Review

Stock Yards Bank & Trust sold out of Apellis Pharmaceuticals (APLS) in Q3 2023, closing a stake of 5,000 shares — an estimated $456K sold.

Stock Yards Bank & Trust first reported a position in APLS in Q2 2022 and held it in 5 quarters. The position peaked at $649K in Q3 2022. 256 funds tracked by Wall St. Rank hold APLS as of Q3 2023.

  • Stock Yards Bank & Trust reported no remaining Apellis Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Stock Yards Bank & Trust sold 5,000 Apellis Pharmaceuticals shares in Q3 2023, an estimated $456K.
  • Stock Yards Bank & Trust first reported a position in Apellis Pharmaceuticals in Q2 2022 and held it in 5 quarters.
  • Stock Yards Bank & Trust's Apellis Pharmaceuticals position peaked at $649K in Q3 2022.
  • 256 funds tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q3 2023.

Based on Stock Yards Bank & Trust's 13F filing for Q3 2023, filed 1 Nov 2023.